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Multi-dimensional TOF-SIMS 
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tissue surface
Ji-Won Park1,2,7,*, Hyobin Jeong3,*, Byeongsoo Kang4, Su Jin Kim1,5, Sang Yoon Park6, 
Sokbom Kang6, Hark Kyun Kim6, Joon Sig Choi5, Daehee Hwang3,4,7 & Tae Geol Lee1,2
Time-of-flight secondary ion mass spectrometry (TOF-SIMS) emerges as a promising tool to identify 
the ions (small molecules) indicative of disease states from the surface of patient tissues. In TOF-
SIMS analysis, an enhanced ionization of surface molecules is critical to increase the number of 
detected ions. Several methods have been developed to enhance ionization capability. However, 
how these methods improve identification of disease-related ions has not been systematically 
explored. Here, we present a multi-dimensional SIMS (MD-SIMS) that combines conventional TOF-
SIMS and metal-assisted SIMS (MetA-SIMS). Using this approach, we analyzed cancer and adjacent 
normal tissues first by TOF-SIMS and subsequently by MetA-SIMS. In total, TOF- and MetA-SIMS 
detected 632 and 959 ions, respectively. Among them, 426 were commonly detected by both 
methods, while 206 and 533 were detected uniquely by TOF- and MetA-SIMS, respectively. Of the 426 
commonly detected ions, 250 increased in their intensities by MetA-SIMS, whereas 176 decreased. 
The integrated analysis of the ions detected by the two methods resulted in an increased number 
of discriminatory ions leading to an enhanced separation between cancer and normal tissues. 
Therefore, the results show that MD-SIMS can be a useful approach to provide a comprehensive list 
of discriminatory ions indicative of disease states.
Time-of-flight secondary ion mass spectrometry (TOF-SIMS) has been used to study surface properties 
of specimens due to its high molecular specificity and surface sensitivity1–3. TOF-SIMS spectra represent 
chemical compositions of positive and negative secondary ions (small molecules) in the very near sur-
face region. Recently, TOF-SIMS has been used to study the surface of complex biological samples such 
as cells4–6 and tissues7–10. Furthermore, TOF-SIMS can be used to characterize secondary ions from the 
surface of tissue samples. Comparative analysis of the detected ions between disease and normal samples 
can reveal the ions indicative of disease states4,9. For example, Yun et al.9 catalogued secondary ions from 
seven gastric cancer and eight normal tissues using TOF-SIMS and found 66 ions discriminating gastric 
cancer tissues from normal ones. Such studies show that TOF-SIMS is emerging as a promising tool to 
identify the ions that reflect disease states from the surface of patient tissues.
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In TOF-SIMS analysis, enhancing the ionization of small molecules from the surface of a speci-
men is important to increase the number of detected ions, and several methods have been developed 
to improve ionization capability. First, Wu et al.11 proposed a matrix-enhanced SIMS analysis where 
a matrix (2,5-dihydroxybenzoic acid) used commonly in matrix assisted laser desorption ionization 
(MALDI) is deposited on the surface of the specimen, followed by TOF-SIMS analysis. In this analysis, 
ion-beam sputtering of the solid mixtures of analytes and matrix resulted in an increased production 
of high mass ions. Second, Linton et al.12 introduced metal-assisted SIMS (MetA-SIMS) analysis where 
Ag is deposited on the low-density poly(ethylene) surface, followed by TOF-SIMS analysis. They found 
that Ag deposition resulted in an increased emission of secondary ions from the surface. Recently, sev-
eral studies13–15 have further demonstrated that submonolayer depositions of silver or gold on the sur-
face improve the ionization of surface molecules. However, how these methods increase the number 
of detected ions and thereby improve the efficiency for identifying disease-related ions has not been 
systematically investigated.
Here, we present a multi-dimensional TOF-SIMS (MD-SIMS) approach for effective profiling of 
the secondary ions from the surface of tissue samples, which can lead to an efficient identification of 
disease-related ions at the tissue surface. This approach first uses conventional TOF-SIMS to analyze the 
fresh surface of the tissues, after which Au is deposited on the surface, followed by TOF-SIMS analy-
sis (i.e., MetA-SIMS). This serial analysis provides multi-dimensional data generated by both the con-
ventional TOF-SIMS and MetA-SIMS. To demonstrate the utility of a MD-SIMS analysis, we analyzed 
ovarian cancer and adjacent normal tissues sequentially using TOF- and MetA-SIMS. The comparison 
of the TOF- and MetA-SIMS data revealed shared and distinct ions detected by the two SIMS methods, 
indicating that particular signals were suppressed and enhanced by MetA-SIMS. By combining the ions 
detected by TOF- and MetA-SIMS, the MD-SIMS analysis produced an increased number of discrimina-
tory ions between cancer and normal tissues, which can be used as indicators of disease states.
Results
MD-SIMS analysis of ovarian cancer and normal tissues. For a comparative analysis of the sec-
ondary ions at the tissue surface, we collected the tissues from 10 ovarian cancer patients. The character-
istics of the patients are summarized in Supplementary Table S1. For each of the 10 ovarian tissues, we 
first performed two serial sectioning. One section was used for H&E staining to identify cancer and adja-
cent normal regions, whereas the other section was used for TOF- and MetA-SIMS analyses (Fig.  1a). 
Based on the H&E staining, we selected 40 different cancer and adjacent normal regions (e.g. boxes in 
Fig. 1a) that contain high densities of cancer and adjacent normal cells, respectively, from the 10 ovarian 
cancer tissues (Methods). Multiple areas in each tissue were analyzed to account for the heterogeneity 
arisen from the varying amounts of cancer cells (see Discussion). For each of the 80 selected regions, we 
performed TOF-SIMS analysis (Fig. 1b, left box). Subsequently, we performed MetA-SIMS analysis after 
depositing Au on the same regions for which TOF-SIMS analysis was performed (Fig. 1b, right box). The 
MetA-SIMS analysis was performed for 50 of the 80 selected regions (30 cancer and 20 adjacent normal 
regions). In each SIMS analysis, we analyzed the secondary ions with both positive and negative modes. 
Thus, these analyses resulted in 80 positive and negative TOF-SIMS spectra and 50 positive and negative 
MetA-SIMS spectra (Fig. 1c).
Comparison of TOF-SIMS with MetA-SIMS data. For each dataset (80 TOF-SIMS spectra or 50 
MetA-SIMS spectra), we identified the ion peaks and then aligned the peaks using TOFSIMS-P as pre-
viously described9. Of these ion peaks, we focused on the peaks that were detected in more than 50% 
of ovarian cancer and normal tissue samples in each dataset (i.e., 20 cancer and 20 normal samples in 
TOF-SIMS datasets; 15 cancer and 10 normal samples in MetA-SIMS dataset), as previously reported9. 
The 50% cutoff was used to ensure statistical reliability in the following analyses of the peaks including 
the comparison of TOF- and MetA-SIMS and the identification of discriminatory ions between ovarian 
cancer and normal tissues (see Discussion). Based on this criterion, we identified 301 positive and 331 
negative ion peaks from the 80 TOF-SIMS spectra, and 388 positive and 571 negative ion peaks from 
the 50 MetA-SIMS spectra (Fig. 2a).
Of these peaks, 426 were detected commonly by both TOF- and MetA-SIMS analyses (Fig. 2b, 1st pie 
chart). Of the 426 shared peaks, 250 were increased in their intensities by MetA-SIMS analysis, compared 
to the TOF-SIMS analysis, indicating enhanced ionization of the corresponding ions by Au deposition 
(Fig. 2c, top). In contrast, 176 showed decreased intensities in MetA-SIMS analysis (Fig. 2c, bottom). This 
suggests that Au deposition can also suppress the ionization of these ions. On the other hand, 739 were 
detected uniquely by TOF-SIMS (206 peaks) or MetA-SIMS analysis (533 peaks), respectively (Fig. 2b, 1st 
pie chart). The 533 peaks uniquely detected by MetA-SIMS analysis comprise 1) Au adducts (189 peaks) 
for which the same ions were detected at m/z-196.97 (Au) by TOF-SIMS analysis (Fig. 2d, top) and 2) the 
344 peaks detected truly uniquely by MetA-SIMS analysis (Fig. 2d, bottom) (Fig. 2b, 2nd pie chart). These 
data indicate that the two SIMS analyses provide complementary information for the compositions of 
the secondary ions from the tissue surface by detecting shared and distinct ions with different intensities.
Discriminatory ions between ovarian cancer and normal tissues. To identify the ions indicative 
of disease states, we next identified the peaks that discriminated the ovarian cancer samples from the 
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normal samples. To this end, we first combined positive and negative ion peaks detected from TOF- and 
MetA-SIMS analyses. From all of these detected peaks, we used only the 632 and 959 peaks in the TOF- 
and MetA-SIMS datasets, respectively, (Fig. 2a), which were detected in more than 50% of ovarian cancer 
and normal tissue samples to ensure their statistical power as discriminatory peaks (see Discussion). 
We then applied two-tailed T-test and also partial least square-discriminant analysis (PLS-DA) to these 
peaks. Of them, we finally selected 99 discriminatory peaks from TOF-SIMS data and 47 discriminatory 
peaks from MetA-SIMS data with P < 0.01 using two-tailed T-test and VIP > 1 obtained from PLS-DA, 
as previously described9 (Fig. 3a; Supplementary Table S2; Methods). Among these discriminatory peaks, 
only one was identified commonly from the TOF- and MetA-SIMS data, while 98 and 46 were identified 
uniquely in TOF- and MetA-SIMS data, respectively (Fig.  3b). The uniquely identified discriminatory 
Figure 1. Overview of the MD-SIMS framework. 
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peaks indicate that MD-SIMS analysis can provide a more comprehensive view of the discriminatory 
signatures between ovarian cancer and normal samples than a single analysis of TOF- or MetA-SIMS. 
Of the 145 discriminatory peaks, four example peaks showing up- or down-regulated in ovarian cancer 
tissues, compared to adjacent normal tissues, are shown in Fig. 3c,d.
Comprehensive signatures to enhance discrimination between ovarian cancer and normal 
tissues. Compared to the conventional TOF-SIMS analysis, the additional MetA-SIMS analysis in 
MD-SIMS analysis increased the number of discriminatory ions (Fig. 3b). The extended list of the dis-
criminatory peaks can provide a better discrimination between ovarian cancer and adjacent normal 
tissues. To test this notion, we applied PLS-DA to the 99 discriminatory peaks (Fig. 3b) identified by the 
conventional TOF-SIMS analysis and also multi-block PLS-DA (MPLS-DA) to the 145 peaks (Fig. 3b) 
identified by MD-SIMS analysis. PLS-DA showed that 68.4% of the separation between ovarian cancer 
and normal samples was achieved by the 99 discriminatory peaks identified by TOF-SIMS analysis. With 
Figure 2. Shared and distinct ions detected by TOF-SIMS and MetA-SIMS analyses. (a). Relationships 
among positive (top) or negative (bottom) peaks measured by TOF-SIMS and MetA-SIMS analyses. (b). 
Proportion of the peaks commonly (shared) and uniquely (unique) detected by TOF-SIMS and MetA-
SIMS analyses. The second pie chart shows the composition of the peaks uniquely detected by MetA-SIMS 
analysis. (c). Examples of the peaks detected commonly by TOF- and MetA-SIMS analyses with enhanced 
and suppressed ionizations in MetA-SIMS analysis, compared to those in TOF-SIMS analysis. (d). Examples 
of an Au adduct peak and a peak uniquely detected by MetA-SIMS analysis.
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these 99 peaks, a partial overlap between the ovarian cancer and normal samples was observed in the 
PLS latent space (Fig. 4a). In contrast, MPLS-DA showed that the use of the additional discriminatory 
peaks identified by MD-SIMS analysis improved the separation to 82.6%, resulting in a reduced overlap 
between the ovarian cancer and normal samples, compared to that observed from PLS-DA using only 
the discriminatory peaks identified by TOF-SIMS analysis (Fig. 4b). This result indicates that MD-SIMS 
analysis provided a comprehensive list of molecular signatures that can better discriminate ovarian can-
cer samples from normal samples.
Discussion
Although TOF-SIMS is a promising tool to identify the secondary ions reflecting disease states at the 
surface of patient tissues, its use has been hampered by the limited capacity of detecting the ions. Thus, 
several methods have been developed to improve the capability to ionize the ions at the surface. This 
has led to an increased number of the detected secondary ions, but the usefulness of these methods to 
efficiently identify the ions indicating disease states has not been systematically explored. In this study, 
we proposed MD-SIMS analysis, a combination of TOF-SIMS and MetA-SIMS analyses. By applying 
MD-SIMS analysis to ovarian cancer and adjacent normal tissues, we demonstrated that MD-SIMS anal-
ysis resulted in a more comprehensive set of the ions associated with disease states, compared to the 
conventional TOF-SIMS analysis.
A cancer tissue often shows heterogeneous molecular signatures across different regions of the tissue. 
The variation in the relative amounts of cancer and normal cells across the different regions mainly 
accounts for the heterogeneity. Different amounts of normal cells in the regions can dilute disease-related 
signatures with different extents. In this study, given the heterogeneity, to identify the ions that represent 
disease states, we performed TOF-SIMS analysis in the following manner. First, for each of 10 cancer 
tissues, we performed TOF-SIMS analyses of 4 different regions (100 × 100 μ m2 per region) that contain 
high densities of the cancer cells based on the H&E staining, assuming that the 4 regions can provide 
sufficient information of cancer-related signatures in each tissue. For comparative analysis, we further 
performed 10 different regions for each of the 4 cancer tissues containing high densities of adjacent 
normal cells. These analyses resulted in the 40 cancer and normal datasets. Compared with the numbers 
of the regions analyzed during the discovery phase in other SIMS and metabolomics studies9,16,17, the 
40 cancer regions can be considered to be sufficiently large to provide meaningful cancer-related signa-
tures. Second, we then identified the discriminatory ions as the ones that showed consistent differences 
Figure 3. Analysis of TOF- and MetA-SIMS datasets. (a). Analytical framework for identification of 
discriminatory ions. (b). Relationships between the discriminatory ions identified from TOF- and MetA-
SIMS datasets. (c–d). Up- or down-regulation of four example discriminatory ions in ovarian cancer tissues 
detected by TOF- (c) and MetA-SIMS analyses (d), compared to normal tissues.
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in their abundances between the 40 cancer and normal datasets. This helps us focus on identification of 
the discriminatory ions that can represent the ovarian cancer states.
In this study, we performed MD-SIMS analysis under a static condition (< 1012 primary ions/cm2), 
assuming that no significant surface damage occurs, as previously reported18. Even under this condition, 
however, organic systems, such as cells or tissues, might be damaged during TOF-SIMS, and MetA-SIMS 
spectra can include the ions resulting from such damage, thus affecting the accuracy of the MD-SIMS 
analysis. To examine this issue, we performed two serial TOF-SIMS analyses under a static condition 
(Case 1) for a region of an ovarian tissue (100 × 100 μ m2). In the MD-SIMS analysis, for a region of an 
ovarian tissue, we performed TOF-SIMS analysis followed by MetA-SIMS analysis (Case 2). In Case 1, 
high correlations (correlation coefficients close to 1) were observed between the intensities of the peaks 
detected by two serial TOF-SIMS analyses (Supplementary Fig. S1a), indicating that despite potential 
tissue damage, two serial TOF-SIMS analyses generated highly reproducible sets of the detected ions. 
In contrast, in Case 2, relatively smaller correlations (correlation coefficients = 0.771 and 0.717 for pos-
itive and negative modes, respectively) were observed between the intensities of the peaks detected by 
TOF- and MetA-SIMS analyses (Supplementary Fig. S1b), indicating that despite potential tissue damage, 
MetA-SIMS analysis could generate a reasonable level of the peaks independent of those detected by the 
initial TOF-SIMS analysis.
To identify discriminatory ions, in this study, we used the peaks detected in more than 50% of ovarian 
cancer and normal tissue samples. The peaks less frequently observed could be either chemical noises 
arisen from contamination or the peaks for real secondary ions that existed in a small number of the 
regions or tissues analyzed. The discriminatory peaks observed in a small number of samples can be 
also meaningful. In this study, however, among the detected peaks, we focused on the peaks that were 
detected in more than a certain percentage of ovarian cancer and normal tissue samples in each dataset, 
as previously reported9, which can ensure statistically reliable comparison of TOF- and MetA-SIMS and 
identification of statistically reliable discriminatory ions that are likely to be detected in new tissues by 
MD-SIMS. To determine the percentage cutoff, we varied the cutoff from 10% to 90% and found, as 
expected, that a high percentage cutoff decreases the number of the peaks analyzed, increasing the false 
negative rate in identification of discriminatory ions, whereas a small cutoff increases the number of the 
peaks, increasing the false positive rate (Supplementary Fig. S2). These data revealed no evidence that 
a particular percentage cutoff should be used. Thus, we chose 50% as a percentage cutoff such that the 
conclusions from the following analyses are likely to be valid at least in half of the samples to be analyzed.
Few approaches have been proposed to identify the molecules for the ions detected by TOF-SIMS19–21, 
which often require significant amounts of efforts and time. In this study, our primary goal was to 
Figure 4. Integrated analysis of TOF- and MetA-SIMS datasets. 3-d PLS-DA score plots for TOF-SIMS 
(a) and MD-SIMS (b). LV1-3, 1st to 3rd PLS latent variables (LVs). The tables show that MD-SIMS enhanced 
the power of discrimination of ovarian cancer samples (red) from normal samples (blue), compared to TOF-
SIMS. X-block, intensities of the 99 discriminatory peaks in TOF-SIMS data; X1- and X2-blocks, intensities 
of the 145 discriminatory peaks in TOF- and MetA-SIMS data, respectively; Y-block, binary vector in which 
ones and zeros represent ovarian cancer and normal samples, respectively. A percent variance captured by an 
LV in X- or Y-blocks indicates the amount of the information in X-block used to explain the amount of the 
separation explained by the LV among the binary values in Y-block.
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propose MD-SIMS to effectively extend the list of the disease-related ions, rather than to demonstrate 
biological meanings of these ions by mapping them into molecules and pathways. Thus, we performed 
no experiments to identify the 145 discriminatory ions. However, it would be important to assign mole-
cules to the discriminatory ions in order to assess whether the extended list of the discriminatory ions by 
MD-SIMS would be useful. We thus employed a previously reported approach that compares the masses 
of the 145 discriminatory ions with those of the TOF-SIMS ions for which the molecules were previously 
identified using the experimental approaches mentioned above22. As a result, we identified the molecules 
for 22 of the 145 discriminatory ions (Supplementary Table S3), including fatty acids (FAs), cholesterol 
(CH), glycerophospholipids (GP), and phosphatidylethanolamines (PE). CH, PE, and GP were identified 
from TOF-SIMS, and FAs were additionally identified from MetA-SIMS, showing that the integrated 
MD-SIMS analysis provided a more comprehensive set of molecules altered in ovarian cancer.
Based on the molecules assigned for the 22 discriminatory ions, we further built a pathway model 
describing altered lipid metabolism in ovarian cancer (Supplementary Fig. S3). In this model, GP and 
PE were increased in ovarian cancer tissues, compared to adjacent normal tissues, whereas FA and CH 
were decreased. Several of these changes have been previously reported to be associated with ovarian 
cancers. For example, altered expression of enzymes [FA synthase (FASN)23, stearoyl-CoA desaturase-1 
(SCD1)24, and lysophosphatidic acid acyltransferase-β (LPAAT-β)25] involved in the GP synthetic path-
way was proposed as a potential indicator of the poor clinical outcome of ovarian cancer patients. Also, 
altered expression of HMG-CoAR(HMGCR), which regulates cholesterol synthesis, was proposed as a 
predictor of recurrence free survival in ovarian cancer26. Moreover, in various cancers, GP or PE, com-
ponents of plasma membrane, are increased during cell proliferation27,28, consistent with up-regulation 
of GP or PE in ovarian cancer detected by MD-SIMS. All these data support potential validity of the 
extended discriminatory ions by MD-SIMS. However, detailed functional studies should be performed 
to demonstrate the validity of the discriminatory ions, together with validation of the discriminatory 
ions in large-scale cohorts. Furthermore, only a limited number of ovarian cancer samples (n = 10) was 
used in this study. Thus, the validity of the discriminatory ions should be tested in large-scale validation 
experiments, together with the detailed functional studies.
Principal component analysis (PCA) has been applied to the TOF-SIMS data to effectively explore the 
data structure in an unsupervised manner29. In this study, however, we only applied PLS-DA to select the 
discriminatory ions based on the VIPs of the ions, together with the T-test. Thus, to examine whether PCA 
can provide additional knowledge of the data structure, we performed PCA using the 1,591 ion peaks 
(632 from TOF-SIMS and 959 from MetA-SIMS) to which PLS-DA was applied to select the discrimina-
tory ions based on their VIPs. The first three PCs captured 54.5% (22.22, 18.97, and 13.30% respectively) 
of the total variance in the data (Supplementary Fig. S4a). PC1 (22.22%) showed no correlation with the 
difference between ovarian cancer and normal tissue samples, suggesting that the data contained a high 
level of variability independent of the difference between cancer and normal samples. However, PC2 
(18.97%) began to show a significant (P = 4.77 × 10−4) correlation with such difference, indicating that 
the data also contained significant amount of information regarding the difference between cancer and 
normal samples (Supplementary Fig. S4b). To understand how PLS-DA handles these variabilities in the 
data independent of the difference between cancer and normal samples, we applied multi-block PLS-DA 
to the same data (Supplementary Fig. S4c). The comparison of both PCA and PLS-DA results showed 
that the application of PLS-DA to the 1,591 ion peaks allowed us to effectively focus on the information 
relevant to the difference between cancer and normal samples, thereby enabling correct identification 
of the discriminatory ions based on the VIPs. Moreover, multi-block PLS-DA further showed how the 
discriminatory ions identified from both TOF- and MetA-SIMS data additively contributed to capturing 
the difference between ovarian cancer and normal samples. In summary, MD-SIMS can be a useful 
approach to provide a more comprehensive list of the discriminatory ions that can be used to understand 
the disease states.
Methods
Sample preparation. Tissues were obtained from 10 ovarian cancer patients hospitalized at the 
National Cancer Center in Korea from 2005 to 2008 with informed consent in accordance with the guide-
lines approved by the institutional review board at the National Cancer Center (approval no. NCCNCS 
09-309)30. Samples were rapidly frozen in liquid nitrogen upon acquisition and then stored at − 80 °C 
before TOF-SIMS analysis. The samples were processed for TOF-SIMS analysis as previously described31. 
Briefly, two serial sections of each tissue of 10 μ m-thickness were generated at − 20°C using a cryostat 
(Leica CM 3050S, Leica Microsystems Inc., IL). The 1st section was affixed to a glass slide and stained 
with hematoxylin and eosin (H&E) to identify the areas enriched with normal or cancer cells. The 2nd 
section was deposited onto a Si wafer that was sonicated with ethanol and acetone for 5 min each, rinsed 
with water, and then stored at − 80 °C until TOF-SIMS analysis. No chemical fixation was done because 
of the possibility that chemical artefacts could be detected by TOF-SIMS. Based on the H&E staining, 
we selected 4 different regions containing high densities of cancer cells from the 2nd section for each of 
the 10 ovarian cancer tissues (40 cancer regions). Also, we selected 40 adjacent normal regions from the 
ovarian tissues. To this end, we first selected 4 of 10 tissues containing high densities of adjacent normal 
cells, based on the H&E staining, and then further selected 10 adjacent normal regions from each of the 
4 ovarian tissues (40 adjacent normal regions). Each selected region was analyzed by TOF-SIMS in both 
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the positive and negative modes. After the TOF-SIMS analysis, Au was deposited onto the tissue surface 
using a Quorum Technologies (Newhaven, East Sussex, U.K.) SC7640 sputter coater. The thickness of 
the gold was controlled to be 1 nm by a FT7607 quartz crystal microbalance stage and a FT7690 film 
thickness monitor. The samples were then analyzed by TOF-SIMS after metal deposition.
TOF-SIMS analysis. We used a TOF-SIMS V instrument (ION-TOF GmbH, Germany) equipped 
with a bismuth liquid metal ion gun (LMIG). A Bi3+ primary beam at 25 keV in a high-current bunched 
mode (pulse width = 0.65 ns and beam diameter = 3 μ m) with a target current of 0.2 pA and a repeti-
tion rate of 5 kHz was used to obtain positive and negative spectra. The analysis area of 100 × 100 μ m2 
(128 × 128 pixels) was randomly rastered by the primary ions and were charge-compensated for the 
tissue samples by low-energy electron flooding. The primary ion dose density was maintained below 
1012 ions/cm2 to ensure a static SIMS condition. Mass resolution was higher than 7000 at m/z < 500 in 
both the positive and negative modes. Positive and negative ion spectra from each sample at specific areas 
were obtained. Positive and negative ion spectra were internally mass calibrated using CH3+, C2H3+, 
C3H5+ and C5H14NO+ peaks, and CH−, C2H−, C4H− and C18H35O2− peaks, respectively. After the calibra-
tion, the resulting mass accuracy was 60 ppm for m/z < 200 and 150 ppm for m/z > 200 on average. Each 
spectrum was exported as an ASCII file.
Analysis of TOF-SIMS or MetA-SIMS data. From each of the spectra generated by TOF-SIMS, the 
peaks were automatically identified using the TOFBAT program in the built-in IonSpec software from 
ION-TOF. We searched for those peaks whose intensities were larger than 20 between 1 and 800 m/z. 
For each peak, the m/z, m/z range, and area of the peak were identified. Using the peaks from all the 
samples, we then applied a computational platform, TOFSIMS-P9, as previously reported for comparative 
analysis of the TOF-SIMS data obtained from cancer and normal samples, which involved 1) refinement 
and alignment of the peaks identified from all the samples and 2) selection of discriminatory ions. The 
same procedure was used to analyze the MetA-SIMS dataset.
Partial least square-discriminant analysis (PLS-DA). PLS-DA was applied to the combined set of 
positive and negative ion peaks detected from TOF-SIMS or MetA-SIMS analysis, as previously described9. 
Briefly, we defined X-block with the intensities of k peaks in n samples (i.e. n  k×  alignment matrix) and 
n  × 1 Y-block with information of sample classes (one for cancer and zero for normal). First, we estimated 
the missing values (less than 50% of intensities in the alignment table) using the k-nearest-neighbor 
imputing method32. Second, we selected the number of latent variables (LVs) as the one for which the 
mean error rate, computed by performing 10-fold cross-validations (CVs) 1000 times, reached the min-
imum as previously described9. Finally, we calculated the mean of variable importance on the projection 
(VIP) values for each peak by performing the 10-fold CV 1000 times using the determined number of 
PLS LVs. We selected the discriminatory ion peaks as the ones with the mean VIP > 133,34.
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